MONIQUE GONZALEZ: Open Payments
NPI 1699215293 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,278 in 66 payments from 10 companies in 2025. Trend: 2023 $28,590 · 2024 $15,092 · 2025 $26,278
Speaker / faculty: $15,753Consulting: $6,456Travel & lodging: $2,190Food & beverage: $1,856Education: $24
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 39 | $24,186 |
| E.R. Squibb & Sons, L.L.C. | 7 | $1,308 |
| Vanda Pharmaceuticals Inc. | 7 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $154 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $114 |
| GENZYME CORPORATION | 1 | $112 |
| ABBVIE INC. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, FANAPT, CAPLYTA, Auvelity, MOUNJARO, DUPIXENT, VRAYLAR.
Industry payments across TX — which companies pay providers there.
